Accessibility Menu
ValiRx Plc logo

ValiRx Plc

(LSE) VAL

Current Price£0.00
Market Cap£2.44M
Since IPO (2006)-100%
5 Year-99%
1 Year-61%
1 Month-8%

ValiRx Plc Financials at a Glance

Market Cap

£2.44M

Revenue (TTM)

£59.38K

Net Income (TTM)

-£3.76M

EPS (TTM)

-£0.01

P/E Ratio

-0.20

Dividend

£0.00

Beta (Volatility)

-0.44 (Low)

Price

£0.00

Volume

16,767,020

Open

£0.00

Previous Close

£0.00

Daily Range

£0.00 - £0.00

52-Week Range

£0.00 - £0.01

Estimated Earnings Date

Jun 10, 2026

VAL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ValiRx Plc

Industry

Biotechnology

CEO

Mark Edward Eccleston, PhD, MBA

Headquarters

Hatfield, CM22 7BD, GB

VAL Financials

Key Financial Metrics (TTM)

Gross Margin

-4%

Operating Margin

-41%

Net Income Margin

-36%

Return on Equity

-49%

Return on Capital

-67%

Return on Assets

-58%

Earnings Yield

-5.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£2.44M

Shares Outstanding

1.32B

Volume

16.77M

Avg. Volume

9.98M

Financials (TTM)

Gross Profit

-£217.22K

Operating Income

-£2.14M

EBITDA

-£1.86M

Operating Cash Flow

-£1.58M

Capital Expenditure

-£38.16K

Free Cash Flow

-£1.62M

Cash & ST Invst.

£1.56M

Total Debt

£11.86K

ValiRx Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

£0.00

N/A

Gross Profit

-£121.62K

-2.9%

Gross Margin

0.00%

N/A

Market Cap

£2.44M

N/A

Market Cap/Employee

£152.66K

N/A

Employees

16

N/A

Net Income

-£838.43K

+19.0%

EBITDA

-£812.32K

+21.4%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

£518.79K

-41.8%

Total Debt

£6.66K

-76.9%

Accounts Receivable

£64.88K

-67.8%

Inventory

£69.00K

N/A

Long Term Debt

£0.00

-100.0%

Short Term Debt

£6.66K

-44.6%

Return on Assets

-57.54%

N/A

Return on Invested Capital

-66.99%

N/A

Free Cash Flow

-£1.00M

+28.6%

Operating Cash Flow

-£993.57K

+10.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GDR.LGenedrive Plc
£0.01+2.08%
TCF.LTheracryf Plc
£0.00+0.00%
NFX.LNuformix plc
£0.00+0.00%
CRTX.LCRISM Therapeutics Corporation
£0.11+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$201.80+0.05%
AALAmerican Airlines Group
$15.71+0.02%
NOKNokia
$13.98-0.06%
SNAPSnap
$5.16-0.10%

Questions About VAL

What is the current price of ValiRx Plc?

ValiRx Plc is trading at £0.00 per share.

What is the 52-week range for ValiRx Plc?

Over the past 52 weeks, ValiRx Plc has traded between £0.00 and £0.01.

How much debt does ValiRx Plc have?

As of the most recent reporting period, ValiRx Plc reported total debt of £11.86K.

How much cash does ValiRx Plc have on hand?

ValiRx Plc reported £1.56M in cash and cash equivalents in its most recent financial results.

What is ValiRx Plc’s dividend yield?

ValiRx Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.